Harry Malech, MD

The National Institute of Allergy and Infectious Diseases · company speakers →

Dr. Malech will present efforts to direct TALENs and CRISPR/Cas9 to revert mutations associated with chronic granulomatous disease.

Is this you? Claim this profile →

No public contact links on file.

Speaking history

ASH Meeting on Hematologic Malignancies

21 August 2026 Chicago, United States “Development of Efficient Genome Targeting for Correction of Chronic Granulomatous Disease in iPS Cells and CD34+ Hematopoietic Stem Cells”

Sourcing speakers for your event?

Browse the speaker directory →